Related Experiment Video
Updated: Oct 22, 2025
05:27
Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
1.9K
RNF38 inhibits osteosarcoma cell proliferation by binding to CRY1
Jian Zhou1,1, Zhen-Yu Tang1,1, Xiao-Liang Sun1,1
1Articular Orthopaedics, The Third Affiliated Hospital of Soochow University, Changzhou 213000, Jiangsu Province, China.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|August 30, 2021
Summary
RNF38 promotes osteosarcoma cell proliferation by activating the PI3K/AKT pathway. This occurs through its interaction with CRY1, a protein that normally inhibits proliferation, revealing a novel regulatory mechanism in osteosarcoma development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The PI3K/AKT pathway is crucial in osteosarcoma development.
- RNF38 and CRY1 are implicated in regulating the AKT pathway and osteosarcoma proliferation, respectively.
Purpose of the Study:
- To investigate the role of RNF38 in osteosarcoma cell proliferation.
- To determine if RNF38 regulates the PI3K/AKT pathway via interaction with CRY1.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) for RNF38 mRNA.
- Western blotting for RNF38, CRY1, and PI3K/AKT pathway proteins.
- Cell proliferation assays (CCK-8, colony formation).
- Co-immunoprecipitation and GST pull-down assays for protein interaction.
Main Results:
- RNF38 expression was elevated in osteosarcoma cells.
- Overexpression of RNF38 enhanced cell proliferation and activated the PI3K/AKT pathway (increased p-AKT, p-mTOR).
- RNF38 directly binds to CRY1.
- Knockdown of RNF38 reduced p-AKT levels, which was partially restored by simultaneous CRY1 knockdown.
Conclusions:
- RNF38 promotes osteosarcoma cell proliferation by activating the PI3K/AKT pathway.
- RNF38 interacts with CRY1, modulating its inhibitory effect on osteosarcoma proliferation.
- This interaction highlights a new mechanism by which RNF38 influences osteosarcoma progression.
More Related Videos
12:35Author Spotlight: Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos
Published on: April 14, 2023
1.6K
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
3.9K
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
5.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.6K
02:15Experimental RNAi
6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
02:26NF-κB-dependent Signaling Pathway
8.0K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
8.0K
01:20The Retinoblastoma Gene
4.3K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
02:23Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
02:34Inhibition of Cdk Activity
5.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K